Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
631.45
566.77
463.93
276.87
310.02
296.70
280.41
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
631.45
566.77
463.93
276.87
310.02
296.70
280.41
Raw Material Cost
254.10
240.60
252.34
127.99
130.18
193.66
165.68
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
73.97
83.34
63.21
21.01
28.88
0.91
20.13
Selling and Distribution Expenses
186.03
150.71
140.89
116.03
113.83
116.45
126.76
Other Expenses
-7.40
-8.33
-6.19
-1.33
-1.91
0.94
-1.15
Total Expenditure (Excl Depreciation)
440.14
391.31
394.53
251.73
253.78
320.45
301.10
Operating Profit (PBDIT) excl Other Income
191.29999999999998
175.5
69.4
25.099999999999998
56.2
-23.700000000000003
-20.7
Other Income
13.98
15.62
1.05
0.01
0.23
1.94
1.69
Operating Profit (PBDIT)
374.45
340.33
204.84
94.09
118.07
-6.02
91.91
Interest
73.97
83.34
63.21
21.01
28.88
0.91
20.13
Exceptional Items
-32.74
-32.00
-36.08
-7.51
0.00
0.00
0.00
Gross Profit (PBDT)
377.34
326.17
211.59
148.88
179.84
103.04
114.74
Depreciation
169.16
149.26
134.39
68.94
61.61
15.80
110.91
Profit Before Tax
98.57
75.73
-28.85
-3.37
27.58
-22.72
-39.13
Tax
29.38
27.58
-3.85
-74.89
0.83
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
69.19
48.16
-25.00
71.52
26.75
-22.72
-39.13
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
69.19
48.16
-25.00
71.52
26.75
-22.72
-39.13
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
69.19
48.16
-25.00
71.52
26.75
-22.72
-39.13
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
228.84
195.43
194.84
202.93
186.03
87.43
91.58
Earnings per share (EPS)
1.86
1.29
-0.74
1.86
0.76
-0.68
-1.19
Diluted Earnings per share
1.86
1.29
-0.74
1.86
0.76
-0.68
-1.19
Operating Profit Margin (Excl OI)
30.3%
30.96%
14.96%
9.08%
18.14%
-8.0%
-7.38%
Gross Profit Margin
42.4%
39.7%
22.75%
23.68%
28.77%
-2.33%
25.6%
PAT Margin
10.96%
8.5%
-5.39%
25.83%
8.63%
-7.66%
-13.95%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 11.40% vs 22.18% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 43.57% vs 292.80% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 11.03% vs 59.32% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -11.16% vs 31.80% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Collegium Pharmaceutical, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
631.45
372.51
258.94
69.51%
Other Operating Income
0.00
0.00
0.00
Total Operating income
631.45
372.51
258.94
69.51%
Raw Material Cost
254.10
76.45
177.65
232.37%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
73.97
22.21
51.76
233.05%
Selling and Distribution Expenses
186.03
115.54
70.49
61.01%
Other Expenses
-7.40
-0.86
-6.54
-760.47%
Total Expenditure (Excl Depreciation)
440.14
205.64
234.50
114.03%
Operating Profit (PBDIT) excl Other Income
191.31
166.87
24.44
14.65%
Other Income
13.98
16.14
-2.16
-13.38%
Operating Profit (PBDIT)
374.45
222.86
151.59
68.02%
Interest
73.97
22.21
51.76
233.05%
Exceptional Items
-32.74
-123.41
90.67
73.47%
Gross Profit (PBDT)
377.34
296.06
81.28
27.45%
Depreciation
169.16
39.85
129.31
324.49%
Profit Before Tax
98.57
37.39
61.18
163.63%
Tax
29.38
14.00
15.38
109.86%
Provisions and contingencies
0
0
0.00
Profit After Tax
69.19
23.39
45.80
195.81%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
69.19
23.39
45.80
195.81%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
69.19
23.39
45.80
195.81%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
228.84
691.16
-462.32
-66.89%
Earnings per share (EPS)
1.86
0.36
1.50
416.67%
Diluted Earnings per share
1.86
0.36
1.50
416.67%
Operating Profit Margin (Excl OI)
30.30%
44.80%
0.00
-14.50%
Gross Profit Margin
42.40%
20.74%
0.00
21.66%
PAT Margin
10.96%
6.28%
0.00
4.68%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 63.14 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 11.40% vs 22.18% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 6.92 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 43.57% vs 292.80% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 36.05 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 11.03% vs 59.32% in Dec 2023
Annual - Interest
Interest 7.40 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -11.16% vs 31.80% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.30%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023






